Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Different Efficacy Between Rehabilitation Therapy and Stem Cells Transplantation in Patients With SCI in China (SCI-III)

This study is currently recruiting participants. (see Contacts and Locations)
Verified June 2013 by General Hospital of Chinese Armed Police Forces
Sponsor:
Information provided by (Responsible Party):
General Hospital of Chinese Armed Police Forces
ClinicalTrials.gov Identifier:
NCT01873547
First received: June 4, 2013
Last updated: June 6, 2013
Last verified: June 2013
  Purpose

The morbidity of spinal cord injury (SCI) is increasing year by year significantly in China. The methods to treat SCI patients in sequela stage update are poor. Though traditional rehabilitation therapy is the routine method to treat SCI in sequela stage, aiming to improve the neurological disorders of these patients, such as sensory disturbance, dyskinesia, autologous adjustment of blood pressure, dysfunction of urination, defecation and perspiration , etc. What's a pity, the efficacy of the rehabilitation therapy is unsatisfactory. Rehabilitation Therapy can prevent the process of muscle atrophy and joint stiffness. However, it can not repair the damaged nerve function. Studies show that mesenchymal stem cell transplantation can remarkably improve the neurological function of SCI in animals without any severe side effect.

In this study, 300 patients will be divided into three groups and the investigators will use mesenchymal stem cells derived from umbilical cord to treat 100 SCI patients. They will also follow up 100 patients who only receive rehabilitation and another 100 patients who accept neither stem cell therapy nor rehabilitation. On this basis, the investigators can compare the efficacy of these two treatments.


Condition Intervention Phase
Spinal Cord Injury
Procedure: cell therapy
Other: rehabilitation
Phase 3

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Single Blind (Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Different Efficacy Between Rehabilitation Therapy and Umbilical Cord Derived Mesenchymal Stem Cells Transplantation in Patients With Chronic Spinal Cord Injury in China

Resource links provided by NLM:


Further study details as provided by General Hospital of Chinese Armed Police Forces:

Primary Outcome Measures:
  • Neurological Function Score(ASIA and Barthel Index) [ Time Frame: Change from baseline at 12 monthes after enrollment or transplantation ] [ Designated as safety issue: Yes ]

Secondary Outcome Measures:
  • Electromyogram and Electroneurophysiologic Test [ Time Frame: Change from baseline at 12 monthes after enrollment or transplantation ] [ Designated as safety issue: Yes ]
  • Blood Test [ Time Frame: Change from baseline at 12 monthes after enrollment or transplantation ] [ Designated as safety issue: Yes ]
    1. red blood cell
    2. white blood cell
    3. platelet count
    4. alanine aminotransferase
    5. aspartate aminotransferase
    6. total bilirubin
    7. albumin


Estimated Enrollment: 300
Study Start Date: June 2012
Estimated Study Completion Date: December 2014
Estimated Primary Completion Date: October 2013 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Active Comparator: rehabilitation
Patients in the group accept rehabilitation for three weeks in hospital and other eleven months in their home under the guidance of physical therapist.
Other: rehabilitation
Patients only receive rehabilitation of limb function.
Other Name: phsical exercise rehabilitation
Experimental: cell therapy
Patients in the group accept cell therapy including four times stem cells transplant via intrathecal injection.
Procedure: cell therapy
Mesenchymal stem cells derived from umbilical cord are transplanted directly into subarachnoid by Lumbar puncture.
No Intervention: control
Patients receive no professional treatment in hospital or rehabilitation centre.

Detailed Description:

Patients enrolled in this study need to finish our whole follow-up survey, which is carried out by clinical doctors and epidemiologist.

  Eligibility

Ages Eligible for Study:   20 Years to 65 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  1. Patients or their curator must be able to give voluntary consent.
  2. Patients have clear history of traumatic injury.
  3. 20 years - 65 years of age can be enrolled.
  4. Both male and female can be enrolled.
  5. The diagnosis of spinal cord injury are confirmed by all of the examinations including MRI, electromyogram and electrophysiology.
  6. The time of injury was longer than 1 year.

Exclusion Criteria:

  1. Mental disorders
  2. Myelitis
  3. Women in pregnancy
  4. Cancer
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01873547

Contacts
Contact: Yihua An, Ph D 0086-10-57976848 doctoran2010@hotmail.com
Contact: Yihua An, Ph D 0086-10-57976848

Locations
China, Beijing
General Hospital of Chinese People's Armed Police Forces Recruiting
Beijing, Beijing, China, 100050
Contact: Yihua An, Ph D    0086-10-57976848    doctoran2010@hotmail.com   
Contact: Rongrong Hua    0086-10-57976866    huarongrong1011@163.com   
Principal Investigator: Yihua An, Ph D         
Sponsors and Collaborators
General Hospital of Chinese Armed Police Forces
Investigators
Study Director: Yihua An, Ph.D the General Hospital of Chinese People's Armed Police Forces
  More Information

No publications provided

Responsible Party: General Hospital of Chinese Armed Police Forces
ClinicalTrials.gov Identifier: NCT01873547     History of Changes
Other Study ID Numbers: 2013-03-04SCI-III
Study First Received: June 4, 2013
Last Updated: June 6, 2013
Health Authority: China: Ministry of Health of Logistics Department in the Chinese People's Armed Police Force

Keywords provided by General Hospital of Chinese Armed Police Forces:
spinal cord injury
cell transplantation
rehabilitation

Additional relevant MeSH terms:
Spinal Cord Injuries
Central Nervous System Diseases
Nervous System Diseases
Spinal Cord Diseases
Trauma, Nervous System
Wounds and Injuries

ClinicalTrials.gov processed this record on November 27, 2014